GlassScriptPhysician profile
Feroze Afzal
NPI 1598029423
$1,099.45
in general payments reported to CMS, 2019-2025
24 companies · $37.91 in 2025
The $37.91 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $516 · 2020: $59.28 · 2021: $153 · 2022: $87.67 · 2023: $99.12 · 2024: $146 · 2025: $37.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $283.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $283.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $286.94 | 2021-2024 | Pipeline, Solitaire X |
| Sunovion Pharmaceuticals INC. | $96.06 | 2019 | |
| Ge Healthcare | $87.88 | 2019 | |
| Microvention, INC. | $87.67 | 2022 | |
| Allergan, INC. | $79.01 | 2019-2021 | |
| Depuy Synthes Sales INC. | $55.81 | 2023-2025 | Cerepak Uniform |
| Stryker Corporation | $55.34 | 2020-2024 | Surpass Evolve |
| Supernus Pharmaceuticals, INC. | $40.41 | 2019 | |
| Novartis Pharmaceuticals Corporation | $30.44 | 2019 | |
| Boston Scientific Corporation | $29.78 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $29.57 | 2019-2020 | |
| Lilly USA, LLC | $28.54 | 2019 | |
| Medtronic USA, INC. | $19.56 | 2019 | |
| Daiichi Sankyo INC. | $19.40 | 2025 | Datroway |
| Novo Nordisk INC | $19.16 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $17.72 | 2019 | |
| Avanir Pharmaceuticals, INC. | $16.08 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $15.54 | 2019 | |
| Tanabe Pharma America, INC. | $15.31 | 2020 | |
| Shire North American Group INC | $14.58 | 2019 | |
| Csl Behring | $13.79 | 2019 | |
| Mallinckrodt Enterprises LLC | $13.74 | 2019 | |
| Integra Lifesciences Corporation | $13.68 | 2021 | |
| Amgen INC. | $13.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Feroze Afzal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.